WilliamS.GilmerMDFellow, American Academy of Neurology

PubMed

• Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.
  Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu ...> ;Brain Stimul. 2015-01-01
• 23 citations
  Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: Acute and six month outcomes
  H. B. Solvason, Mustafa M. Husain, Paul B. Fitzgerald, Peter B. Rosenquist, William V. McCall, James Kimball, William S. Gilmer, Mark A. Demitrack, Sarah H. Lisanby> ;Brain Stimulation. 2014 Mar 1
• Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for...
  Cook, I. A.,Hunter, A. M.,Gilmer, W. S.,Iosifescu, D. V.,Zisook, S.,Burgoyne, K. S.,Howland, R. H.,Trivedi, M. H.,Jain, R.,Greenwald, S.,Leuchter, A. F.> ;J Clin Psychiatry. 2013 Jan
• Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
  Fintelmann RE, Gilmer W, Bloomer MM, Jeng BH> ;Arch. Ophthalmol.. 2011-01-01
• 64 citations
  Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression
  R. Correa, Hagop S. Akiskal, William S. Gilmer, Andrew A. Nierenberg, Madhukar H. Trivedi, Sidney Zisook> ;Journal of Affective Disorders. 2010 Dec 1
• 98 citations
  Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-mo...
  Philip G. Janicak, Ziad Nahas, Sarah H. Lisanby, H. Brent Solvason, Shirlene Sampson, William M. McDonald, Lauren B. Marangell, Peter B. Rosenquist, W. Vaughn McCall, ...> ;Brain Stimulation. 2010 Oct 1
• 68 citations
  Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
  Andrew F. Leuchter, Mustafa M. Husain, Ian A. Cook, Madhukar H. Trivedi, S. R. Wisniewski, William S. Gilmer, James F. Luther, Maurizio Fava, A.J. Rush> ;Psychological Medicine. 2010 Feb 1
• A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder.
  Ghaemi, S.N., Gilmer, W.S., Dunn, R.T., Hanlon, R.E., Kemp, D.E., Bauer, A.D., Chriki, L., Filkowski, M.M., Harvey, P.D.> ;J Clin Psychopharmacol. 2009-06-01
• Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
  Gilmer, W.S., Gollan, J.K., Wisniewski, S.R., Howland, R.H., Trivedi, M.H., Miyahara, S., Fleck, J., Thase, M.E., Alpert, J.E., Nierenberg, A.A., Warden, D., Fava, M.,...> ;J Clin Psychiatry. 2008 Aug
• Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study.
  Ghaemi, S.N., Gilmer, W.S., Goldberg, J.F., Zablotsky, B., Kemp, D.E., Kelley, M.E., Bauer, A.D., Fleck, J., Filkowski, M.M., Stan, V.A., Dunn, R.T.> ;J Clin Psychiatry. 2007 Dec
• Effect of age at onset on the course of major depressive disorder.
  Zisook, S., Lesser, I., Stewart, J.W., Wisniewski, S.R., Balasubramani, G.K., Fava, M., Gilmer, W.S., Dresselhaus, T.R., Thase, M.E., Nierenberg, A.A., Trivedi, M.H., ...> ;Am J Psychiatry. 2007 Oct
• Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.
  Kemp, D.E., Dago, P.L., Straus, J.L., Fleck, J., Karaffa, M., Gilmer, W.S.> ;J Clin Psychopharmacol. 2007 Jun
• An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder.
  Kemp, D.E., Gilmer, W.S., Fleck, J., Dago, P.L.> ;CNS Spectr. 2007 Feb
• Human immunodeficiency virus and depression in primary care: a clinical review.
  Colibazzi, T., Hsu, T.T., Gilmer, W.S.> ;Prim Care Companion J Clin Psychiatry. 2006
• Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project.
  Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, Yohanna D, Khan A, Alpert J> ;Acta Psychiatr Scand. 2005-12-01
• 6 citations
  Anticonvulsants in the treatment of mood disorders: assessing current and future roles.
  William S. Gilmer> ;Expert Opinion on Pharmacotherapy. 2001 Oct 1
• 9 citations
  Neurologic problems of the lower extremity associated with HIV and AIDS.
  W S Gilmer> ;Clinics in Podiatric Medicine and Surgery. 1998 Apr 1
• Neurologic conditions affecting the lower extremities in HIV infection.
  Gilmer WS> ;J Am Podiatr Med Assoc. 1995-07-01
• 2 citations
  Neuropsychiatric aspects of AIDS and psychopharmacologic management.
  William S. Gilmer, Busch Ka> ;Psychiatric Medicine. 1991 Jan 1
• Physicians and the long arm of the law: how far does it reach?
  Gilmer W> ;J Leg Med (N Y). 1977-04-01
• Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
  Friedman, E. S., Wisniewski, S. R., Gilmer, W., Nierenberg, A. A., Rush, A. J., Fava, M., Zisook, S., Balasubramani, G. K., Trivedi, M. H.> ;Depress Anxiety. 2009 Jan 01
• Mixed depression: A study of its phenomenology and relation to treatment response.
  Pae, C. U., Vöhringer, P. A., Holtzman, N. S., Thommi, S. B., Patkar, A., Gilmer, W., Ghaemi, S. N.> ;J Affect Disord. 2012 Feb
• Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomize...
  Lisanby, S. H., Husain, M. M., Rosenquist, P. B., Maixner, D., Gutierrez, R., Krystal, A., Gilmer, W., Marangell, L. B., Aaronson, S., Daskalakis, Z. J., Canterbury, R...> ;Neuropsychopharmacology. 2009 Jan
• Early experience and depressive disorders: human and non-human primate studies.
  Gilmer, W. S., McKinney, W. T.> ;J Affect Disord. 2003 Jul
• Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
  Leuchter, A. F., Cook, I. A., Marangell, L. B., Gilmer, W. S., Burgoyne, K. S., Howland, R. H., Trivedi, M. H., Zisook, S., Jain, R., McCracken, J. T., Fava, M., Iosif...> ;Psychiatry Res. 2009 Sep 30
• Join now to see all